Alessio Aligi Cogoni

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Chronic Kidney Disease

Metastatic Colorectal Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Carmine Pinto, Armando Orlandi, Nicola Normanno, Evaristo Maiello, Maria Alessandra Calegari, Lorenzo Antonuzzo, Roberto Bordonaro, Maria G Zampino, Sara Pini, Francesca Bergamo, Giuseppe Tonini, Antonio Avallone, Tiziana P Latiano, Gerardo Rosati, Alessio Aligi Cogoni, Alberto Ballestrero, Alberto Zaniboni, Mario Roselli, Stefano Tamberi, Carlo Barone
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Carmine Pinto, Armando Orlandi, Nicola Normanno, Evaristo Maiello, Maria Alessandra Calegari, Lorenzo Antonuzzo, Roberto Bordonaro, Maria G Zampino, Sara Pini, Francesca Bergamo, Giuseppe Tonini, Antonio Avallone, Tiziana P Latiano, Gerardo Rosati, Alessio Aligi Cogoni, Alberto Ballestrero, Alberto Zaniboni, Mario Roselli, Stefano Tamberi, Carlo Barone
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Carmine Pinto, Armando Orlandi, Nicola Normanno, Evaristo Maiello, Maria Alessandra Calegari, Lorenzo Antonuzzo, Roberto Bordonaro, Maria G Zampino, Sara Pini, Francesca Bergamo, Giuseppe Tonini, Antonio Avallone, Tiziana P Latiano, Gerardo Rosati, Alessio Aligi Cogoni, Alberto Ballestrero, Alberto Zaniboni, Mario Roselli, Stefano Tamberi, Carlo Barone
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Carmine Pinto, Armando Orlandi, Nicola Normanno, Evaristo Maiello, Maria Alessandra Calegari, Lorenzo Antonuzzo, Roberto Bordonaro, Maria G Zampino, Sara Pini, Francesca Bergamo, Giuseppe Tonini, Antonio Avallone, Tiziana P Latiano, Gerardo Rosati, Alessio Aligi Cogoni, Alberto Ballestrero, Alberto Zaniboni, Mario Roselli, Stefano Tamberi, Carlo Barone
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Carmine Pinto, Armando Orlandi, Nicola Normanno, Evaristo Maiello, Maria Alessandra Calegari, Lorenzo Antonuzzo, Roberto Bordonaro, Maria G Zampino, Sara Pini, Francesca Bergamo, Giuseppe Tonini, Antonio Avallone, Tiziana P Latiano, Gerardo Rosati, Alessio Aligi Cogoni, Alberto Ballestrero, Alberto Zaniboni, Mario Roselli, Stefano Tamberi, Carlo Barone
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Carmine Pinto, Armando Orlandi, Nicola Normanno, Evaristo Maiello, Maria Alessandra Calegari, Lorenzo Antonuzzo, Roberto Bordonaro, Maria G Zampino, Sara Pini, Francesca Bergamo, Giuseppe Tonini, Antonio Avallone, Tiziana P Latiano, Gerardo Rosati, Alessio Aligi Cogoni, Alberto Ballestrero, Alberto Zaniboni, Mario Roselli, Stefano Tamberi, Carlo Barone
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)